NO310069B1 - Nye-4-(oksyalkoksyfenyl)-3-oksy-piperidiner for behandling av hjerte- og nyreinsuffisiens - Google Patents

Nye-4-(oksyalkoksyfenyl)-3-oksy-piperidiner for behandling av hjerte- og nyreinsuffisiens Download PDF

Info

Publication number
NO310069B1
NO310069B1 NO980954A NO980954A NO310069B1 NO 310069 B1 NO310069 B1 NO 310069B1 NO 980954 A NO980954 A NO 980954A NO 980954 A NO980954 A NO 980954A NO 310069 B1 NO310069 B1 NO 310069B1
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
phenyl
ylmethoxy
naphthalen
Prior art date
Application number
NO980954A
Other languages
English (en)
Norwegian (no)
Other versions
NO980954L (no
NO980954D0 (no
Inventor
Alfred Binggeli
Volker Breu
Daniel Bur
Walter Fischli
Rolf Gueller
Hans-Peter Maerki
Georges Hirth
Marcel Mueller
Christian Oefner
Heinz Stadler
Eric Vieira
Maurice Wilhelm
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO980954D0 publication Critical patent/NO980954D0/no
Publication of NO980954L publication Critical patent/NO980954L/no
Publication of NO310069B1 publication Critical patent/NO310069B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NO980954A 1995-09-07 1998-03-05 Nye-4-(oksyalkoksyfenyl)-3-oksy-piperidiner for behandling av hjerte- og nyreinsuffisiens NO310069B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH254895 1995-09-07
CH187696 1996-07-26
PCT/EP1996/003803 WO1997009311A1 (de) 1995-09-07 1996-08-29 Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz

Publications (3)

Publication Number Publication Date
NO980954D0 NO980954D0 (no) 1998-03-05
NO980954L NO980954L (no) 1998-04-28
NO310069B1 true NO310069B1 (no) 2001-05-14

Family

ID=25688898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980954A NO310069B1 (no) 1995-09-07 1998-03-05 Nye-4-(oksyalkoksyfenyl)-3-oksy-piperidiner for behandling av hjerte- og nyreinsuffisiens

Country Status (27)

Country Link
US (2) US6051712A (da)
EP (1) EP0863875B1 (da)
JP (1) JP3648251B2 (da)
KR (1) KR100384979B1 (da)
CN (1) CN1256326C (da)
AT (1) ATE242213T1 (da)
BR (1) BR9610385A (da)
CA (1) CA2230931C (da)
CY (1) CY2488B1 (da)
CZ (1) CZ292327B6 (da)
DE (1) DE59610509D1 (da)
DK (1) DK0863875T3 (da)
ES (1) ES2201192T3 (da)
HK (1) HK1016177A1 (da)
HU (1) HUP9900926A3 (da)
IL (1) IL123293A (da)
MA (1) MA23967A1 (da)
MY (1) MY121967A (da)
NO (1) NO310069B1 (da)
NZ (1) NZ315677A (da)
PL (1) PL193686B1 (da)
PT (1) PT863875E (da)
RU (1) RU2167865C2 (da)
SA (1) SA96170317B1 (da)
TR (1) TR199800409T1 (da)
TW (1) TW474932B (da)
WO (1) WO1997009311A1 (da)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221921B1 (hu) 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
WO1998051668A1 (en) 1997-05-14 1998-11-19 Neurosearch A/S Piperidine derivatives as neurotransmitter re-uptake inhibitors
AU7708998A (en) 1997-05-29 1998-12-30 Smithkline Beecham Corporation Novel process
AU9740998A (en) * 1997-09-08 1999-03-29 F. Hoffmann-La Roche Ag Piperidine derivatives against malaria
CN1305470A (zh) 1998-04-10 2001-07-25 日本烟草产业株式会社 脒化合物
US6268499B1 (en) 1998-08-10 2001-07-31 Hoffman-La Roche Inc. Process and intermediates for preparation of substituted piperidine-epoxides
US6274735B1 (en) 1998-08-10 2001-08-14 Hoffmann-La Roche Inc. Process and intermediates for preparation of substituted piperidines
WO2000063173A1 (en) * 1999-04-14 2000-10-26 F. Hoffmann-La Roche Ag Process for the preparation of substituted piperidines
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
AU780009B2 (en) * 1999-08-31 2005-02-24 Merck Sharp & Dohme Corp. Heterocyclic compounds and methods of use thereof
CN1199954C (zh) 1999-10-15 2005-05-04 弗·哈夫曼-拉罗切有限公司 苯并二氮杂䓬衍生物
KR20030011894A (ko) * 2000-06-13 2003-02-11 바스프 악티엔게젤샤프트 5-페닐 치환된 2-(시아노아미노)피리미딘 살균제
WO2002076440A2 (en) * 2001-03-23 2002-10-03 Elan Pharmaceuticals, Inc. Methods of treating alzheimer's disease with piperidin derivates
NZ533158A (en) * 2001-11-19 2006-09-29 Elan Pharm Inc 3,4-Disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines and piperazines
KR100783863B1 (ko) 2002-04-29 2007-12-10 액테리온 파마슈티칼 리미티드 7-아릴-3,9-디아자바이사이클로(3.3.1)논-6-엔 유도체 및고혈압, 심혈관 질환 또는 신장 질환의 치료에서 레닌저해물질로써 이들의 용도
CA2490138A1 (en) * 2002-06-27 2004-01-08 Actelion Pharmaceuticals Ltd. Novel tetrahydropyridine derivatives as renin inhibitors
US7705016B2 (en) 2003-02-13 2010-04-27 Albert Einstein College Of Medicine Of Yeshiva University Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus
US20040204455A1 (en) * 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
AU2004234040A1 (en) * 2003-04-28 2004-11-11 Actelion Pharmaceuticals Ltd Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
EP1620403B1 (en) * 2003-04-29 2007-11-28 Actelion Pharmaceuticals Ltd. Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives
EP1622907A1 (en) * 2003-04-30 2006-02-08 Actelion Pharmaceuticals Ltd. Azabicyclononene derivatives
KR20060008937A (ko) * 2003-04-30 2006-01-27 액테리온 파마슈티칼 리미티드 레닌 억제제로서 3-위치에 헤테로원자를 갖는9-아자비사이클로[3.3.1]논-6-엔 유도체
CN1780833A (zh) * 2003-04-30 2006-05-31 埃科特莱茵药品有限公司 托品烷衍生物及其作为血管紧张肽转化酶抑制剂的应用
BRPI0409882A (pt) * 2003-05-02 2006-05-23 Actelion Pharmaceuticals Ltd compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
ES2327684T3 (es) * 2003-07-24 2009-11-02 Euro-Celtique S.A. Compuestos heteroaril-tetrahidropiridilo utiles para el tratamiento o la prevencion del dolor.
TW200900399A (en) 2003-10-01 2009-01-01 Speedel Experimenta Ag Organic compounds
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
JP2007509099A (ja) * 2003-10-23 2007-04-12 アクテリオン ファマシューティカルズ リミテッド 新規ジアザビシクロノネンおよび新規極性側鎖を有するテトラヒドロピリジン誘導体
AU2004293177B2 (en) 2003-11-26 2008-10-23 Novartis Ag 4-phenylpiperidine derivatives as renin inhibitors
TW200605867A (en) 2004-03-17 2006-02-16 Novartis Ag Use of organic compounds
JP2007223901A (ja) * 2004-03-24 2007-09-06 Takeda Chem Ind Ltd 複素環化合物およびその用途
AR053406A1 (es) * 2004-07-09 2007-05-09 Speedel Experimenta Ag Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas
EP1786814B1 (en) 2004-08-25 2010-03-31 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives as renin inhibitors
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
MX2007009004A (es) * 2005-01-28 2007-09-14 Actelion Pharmaceuticals Ltd Ciclopropil-(2,3-dimetilbencidamida del acido 7-{4-[2-(2,6-dicloro-4-metilfenoxi) etoxi] fenil}-3,9-diazabiciclo [3.3.31]non-6-en-s-carboxilico como inhbidores de renina para el tratamiento de hipertension.
AR055756A1 (es) 2005-03-31 2007-09-05 Speedel Experimenta Ag Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos
EP1707202A1 (de) * 2005-03-31 2006-10-04 Speedel Experimenta AG Organische Verbindungen
EP1897879A3 (en) 2005-03-31 2008-06-11 Speedel Experimenta AG 2,4,5-substituted piperidines as renin inhibitors
ES2352564T3 (es) * 2005-03-31 2011-02-21 Novartis Ag Piperidinas sustituidas.
TW200722424A (en) 2005-03-31 2007-06-16 Speedel Experimenta Ag Substituted piperidines
WO2006103275A1 (en) * 2005-03-31 2006-10-05 Speedel Experimenta Ag 3,4,5-substituted piperidines as renin inhibitors
GB0508992D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
GB0510810D0 (en) * 2005-05-26 2005-06-29 Novartis Ag Organic compounds
MX2007014722A (es) 2005-05-27 2008-02-15 Actelion Pharmaceuticals Ltd Nuevos derivados de amida de acido piperidin carboxilico.
WO2006131884A2 (en) * 2005-06-07 2006-12-14 Actelion Pharmaceuticals Ltd Thiazole substituted diazabicyclononane or-nonene derivatives as renin inhibitors
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
RU2422442C2 (ru) 2005-07-29 2011-06-27 Ф. Хоффманн-Ля Рош Аг Производные индол-3-ил-карбонил-пиперидина и пиперазина
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
BRPI0620736A2 (pt) 2005-12-30 2011-12-20 Novartis Ag compostos orgánicos
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
CN101379033A (zh) 2006-02-02 2009-03-04 埃科特莱茵药品有限公司 新颖二级胺
US8084485B2 (en) 2006-03-31 2011-12-27 Vitae Pharmaceuticals, Inc. 6-(aminoalkyl)indazoles
EP2431368B1 (en) 2006-05-19 2014-08-27 AbbVie Bahamas Ltd. CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
EP2044059A1 (en) * 2006-06-08 2009-04-08 Speedel Experimenta AG 2,5-disubstituted piperidines
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
JP2010510176A (ja) * 2006-11-17 2010-04-02 メルク フロスト カナダ リミテツド レニン阻害剤
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
EP1987834A3 (en) 2007-02-13 2008-11-19 Speedel Experimenta AG Substituted piperidines as therapeutic compounds
EP2137167B1 (en) * 2007-04-19 2011-08-10 F. Hoffmann-La Roche AG Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
DK2142529T3 (da) 2007-04-27 2014-02-10 Purdue Pharma Lp Trpv1-antagonister og anvendelser deraf
ES2541107T3 (es) 2007-06-25 2015-07-16 Novartis Ag Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina
US8183381B2 (en) * 2007-07-19 2012-05-22 Metabolex Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
EP2018862A1 (en) 2007-07-25 2009-01-28 Speedel Experimenta AG Substituted piperidines as therapeutic compounds
AR068887A1 (es) 2007-10-18 2009-12-16 Speedel Experimenta Ag Piperidinas trisustituidas
AR069005A1 (es) 2007-10-25 2009-12-23 Speedel Experimenta Ag Piperidinas 4,4-disustituidas
TW200934499A (en) * 2007-11-02 2009-08-16 Speedel Experimenta Ag 4,4-disubstituted piperidines
TW200932241A (en) 2007-12-05 2009-08-01 Speedel Experimenta Ag Organic compounds
WO2009106599A2 (en) * 2008-02-29 2009-09-03 Novartis Ag Substituted piperidines as therapeutic compounds
DK2280704T3 (da) * 2008-03-31 2015-06-29 Cymabay Therapeutics Inc Oxymethylenarylforbindelser og anvendelser deraf
WO2009135299A1 (en) 2008-05-05 2009-11-12 Merck Frosst Canada Ltd. 3, 4 - substituted piperidine derivatives as renin inhibitors
KR20110026481A (ko) * 2008-06-20 2011-03-15 메타볼렉스, 인코포레이티드 아릴 gpr119 작동약 및 이의 용도
WO2010013849A1 (ja) * 2008-08-01 2010-02-04 日本ケミファ株式会社 Gpr119作動薬
EP2163245A1 (en) 2008-09-10 2010-03-17 Novartis Ag Renin inhibitors for the treatment of psoriasis
JP2010090110A (ja) * 2008-09-12 2010-04-22 Sumitomo Chemical Co Ltd N−置換−トランス−4−アジドピペリジン−3−オールの製造方法
JP2012511514A (ja) * 2008-12-10 2012-05-24 メルク・カナダ・インコーポレイテツド レニン阻害剤としての3,4−置換ピペリジン誘導体
US20120115907A1 (en) 2009-04-24 2012-05-10 Cadila Healthcare Limited Novel compounds as inhibitors of renin
WO2011030139A1 (en) 2009-09-11 2011-03-17 Astrazeneca Ab 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
US8410127B2 (en) 2009-10-01 2013-04-02 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
ES2676209T3 (es) 2010-06-23 2018-07-17 Metabolex Inc. Composiciones de 5-etil-2-{4-[4-(4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
US20120184572A1 (en) * 2011-01-13 2012-07-19 Metabolex, Inc. Aryl gpr119 agonists and uses thereof
EP2723732B1 (en) 2011-06-22 2017-01-18 Purdue Pharma LP Trpv1 antagonists including dihydroxy substituent and uses thereof
WO2013088452A2 (en) 2011-11-11 2013-06-20 Sun Pharma Advanced Research Company Ltd. Quinoline derivatives as renin inhibitors
WO2013084241A1 (en) 2011-12-09 2013-06-13 Cadila Healthcare Limited Compounds as inhibitors of renin
CN104370813A (zh) * 2014-10-22 2015-02-25 上海大学 异喹啉-6-甲醛的制备方法
US10292983B2 (en) 2016-08-03 2019-05-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN110041212B (zh) * 2019-05-21 2020-10-02 吉林大学 一种含氟多胺单体及其制备方法、一种聚酰亚胺及其制备方法和一种聚酰亚胺膜

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545792B2 (de) * 1965-02-27 1975-08-07 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 4-Hydroxyplperidinen
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
US5545658A (en) * 1991-03-26 1996-08-13 Hoffman-La Roche Inc. Amino acid derivatives

Also Published As

Publication number Publication date
PL325425A1 (en) 1998-07-20
HK1016177A1 (en) 1999-10-29
BR9610385A (pt) 1999-07-06
MX9801814A (es) 1998-08-30
JPH11500447A (ja) 1999-01-12
NZ315677A (en) 2000-02-28
CZ68498A3 (cs) 1998-10-14
NO980954L (no) 1998-04-28
CA2230931C (en) 2009-05-19
JP3648251B2 (ja) 2005-05-18
RU2167865C2 (ru) 2001-05-27
DK0863875T3 (da) 2003-12-01
CY2488B1 (en) 2005-06-03
KR100384979B1 (ko) 2003-10-17
TR199800409T1 (xx) 1998-05-21
WO1997009311A1 (de) 1997-03-13
CN1256326C (zh) 2006-05-17
EP0863875A1 (de) 1998-09-16
EP0863875B1 (de) 2003-06-04
US6150526A (en) 2000-11-21
KR19990044459A (ko) 1999-06-25
IL123293A (en) 2003-06-24
HUP9900926A3 (en) 2002-12-28
NO980954D0 (no) 1998-03-05
ES2201192T3 (es) 2004-03-16
PT863875E (pt) 2003-10-31
US6051712A (en) 2000-04-18
CA2230931A1 (en) 1997-03-13
CN1202152A (zh) 1998-12-16
ATE242213T1 (de) 2003-06-15
PL193686B1 (pl) 2007-03-30
MA23967A1 (fr) 1997-04-01
CZ292327B6 (cs) 2003-09-17
MY121967A (en) 2006-03-31
DE59610509D1 (de) 2003-07-10
TW474932B (en) 2002-02-01
SA96170317B1 (ar) 2006-05-13
IL123293A0 (en) 1998-09-24
AU6743296A (en) 1997-03-27
HUP9900926A2 (hu) 1999-09-28
AU708616B2 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
NO310069B1 (no) Nye-4-(oksyalkoksyfenyl)-3-oksy-piperidiner for behandling av hjerte- og nyreinsuffisiens
AU700837B2 (en) 1,4-di-substituted piperidine derivatives
JP2713394B2 (ja) トリアゾール化合物合成用中間体
US11098032B2 (en) Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
US7217740B2 (en) Diarylsulfones as 5-HT2A antagonists
CA2454613A1 (en) Substituted anilinic piperidines as mch selective antagonists
US9475795B2 (en) Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
NO320803B1 (no) Renin-inhibitorer, fremstilling av disse, fremstilling av preparater, samt anvendelse for fremstilling av medikamenter.
US7101892B2 (en) Sulfone derivatives as 5-HT7 receptor ligands
EP0680962A2 (en) Heterocyclic compounds
KR19980703644A (ko) 트리아졸 항진균제
JP3622882B2 (ja) トリアゾール誘導体を含有する医薬
JP2902345B2 (ja) トリアゾール抗真菌剤
MXPA98001814A (en) New 4- (oxyalcoxyphenyl) -3-oxy-piperidines for the treatment of heart and rejuvenation insufficiency
EP3212636B1 (en) New pyridinyloxy- and phenyloxy-pyrazolyl compounds
US4518713A (en) Analgesic substituted-1-aminoalkylamino-4-aryloxypiperidines
US12030871B2 (en) Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
JPH06306025A (ja) ジアリールアルカン誘導体

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees